Surgical Indications for Goiter with Background Hashimoto's Thyroiditis: Institutional Experience

被引:7
作者
Bhargav, P. R. K. [1 ]
Shekhar, S. [2 ]
机构
[1] Mamata Med Coll & Hosp, Dept Endocrine Surg, Khammam, Andhra Pradesh, India
[2] Mamata Med Coll & Hosp, Dept Gen Surg, Khammam, Andhra Pradesh, India
关键词
Hashimoto's thyroiditis; Thyroxine; Surgery; AUTOIMMUNE-THYROIDITIS; THYROIDECTOMY; SURGERY; DISEASE; CANCER;
D O I
10.1007/s12262-011-0344-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hashimoto's thyroiditis (HT) is usually treated conservatively with thyroxine. Its incidence is higher in Iodine sufficient areas and may require surgery for associated nodularity or complications. A retrospective study on surgically treated HT cases was conducted in a teritiary care teaching hospital in an Iodine sufficient area of Southern India. 34 cases of goiter with associated HT, who underwent thyroidectomy between 2007 and 2010 were analysed for indications of surgery. Minimum follow-up period was 6 months. F:M ratio was 31:3 with mean age of 41.3 years. Goiter was diffuse in 41% and nodular in 59%. 16 (47%) of patients were hypothyroid. Autoimmune association was found in 35%. Commonest surgery done was hemithyroidectomy in 12 (35%) followed by subtotal thyroidectomy in 10 cases. Most frequent indication for surgery was nodular goiter in 12 (35%) followed by associated malignancy, persistent goiter, pressure symptoms and painful thyroiditis. Histopathology showed diffuse HT alone in 12 (35%) and rest of the cases had HT as a component synchronous with other pathologies. Associated pathologies were benign multinodular goiter (6), colloid nodule (6), papillary cancer (5), follicular adenoma (4), cyst (1). Surgery for HT is primarily indicated for associated pathologies like dominant nodule, suspicious or proven malignancy, persistent goiter, painful thyroiditis, pressure symptoms and rarely for HT perse. Rate of surgery for HT associated goiter appears to be higher in Iodine sufficient areas, the cause of which needs to be studied further.
引用
收藏
页码:414 / 418
页数:5
相关论文
共 26 条
  • [1] BALOCH, 2003, THYROID, V13, P3
  • [2] Baskin HJ., 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, V8, P457, DOI [10.4158/1934-2403-8.6.457, DOI 10.4158/1934-2403-8.6.457]
  • [3] Bhatia Alka, 2007, Cytojournal, V4, P10, DOI 10.1186/1742-6413-4-10
  • [4] BURROW GN, 2009, COMPREHENSIVE HDB IO, P866
  • [5] Carli A F, 2002, Minerva Chir, V57, P117
  • [6] HASHIMOTOS THYROIDITIS AND THYROID-CANCER - INDICATIONS FOR OPERATION
    CLARK, OH
    GREENSPAN, FS
    DUNPHY, JE
    [J]. AMERICAN JOURNAL OF SURGERY, 1980, 140 (01) : 65 - 71
  • [7] CROYLE PH, 1978, AM SURGEON, V44, P559
  • [8] INFLUENCE OF THYROXINE TREATMENT ON THYROID SIZE AND ANTITHYROID PEROXIDASE ANTIBODIES IN HASHIMOTO THYROIDITIS
    HEGEDUS, L
    HANSEN, JM
    FELDTRASMUSSEN, U
    HANSEN, BM
    HOIERMADSEN, M
    [J]. CLINICAL ENDOCRINOLOGY, 1991, 35 (03) : 235 - 238
  • [9] CANCER RISKS IN PATIENTS WITH CHRONIC LYMPHOCYTIC THYROIDITIS
    HOLM, LE
    BLOMGREN, H
    LOWHAGEN, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (10) : 601 - 604
  • [10] CHRONIC LYMPHOCYTIC (HASHIMOTOS) THYROIDITIS IN KUWAIT DIAGNOSED BY FINE-NEEDLE ASPIRATES
    KAPILA, K
    SATHAR, SA
    ALRABAH, NA
    PRAHASH, A
    SESHADRI, MS
    [J]. ANNALS OF SAUDI MEDICINE, 1995, 15 (04) : 363 - 366